Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery 2024-12-18 13:09
U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab) 2024-12-18 11:50
Fosun International Awarded TVB's Highest Honor "Outstanding ESG Award" 2024-12-18 11:43
Neurizon Files IND Application to Support HEALEY ALS Platform Trial 2024-12-18 10:59
Everest Medicines Announces the First Prescription of VELSIPITY® in the Greater Bay Area, Officially Benefiting Mainland China Patients 2024-12-18 08:00
Complete Genomics Adds Eurofins Clinical Enterprise, LLC to its Sequencing Service Provider Program 2024-12-17 22:00
Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary 2024-12-17 21:30
Xinhua Silk Road: Why is Pien Tze Huang selected as one of China's brands favored by foreigners in 2024 2024-12-17 20:40
Great Bay Bio Completes First Close of Series B Financing 2024-12-17 16:42
Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis 2024-12-17 11:48
SK Biopharmaceuticals Inks Research Collaboration Agreement with ProEn Therapeutics Further Accelerating Expansion of Oncology Research and Pipeline for Global Competitiveness in Radiopharmaceuticals 2024-12-17 08:20
Samsung Biologics listed among top most sustainable companies in Dow Jones Sustainability World Index 2024-12-17 07:51
Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg 2024-12-16 22:08
Nona Biosciences Announces Discovery Collaboration with Candid Therapeutics for Next-Generation T-Cell Engagers 2024-12-16 20:03
HiRO Forges Strategic Partnership with CHA University Bundang Medical Center in South Korea 2024-12-16 10:30
Innovent and Lilly Expand Collaboration Through Agreement on Commercialization Rights for Jaypirca® (pirtobrutinib) in Mainland China 2024-12-16 07:55
Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-time Delivery, Sustainability, and Competitive Costs 2024-12-15 13:30
Alphamab Oncology Presented the Phase II Clinical Data of KN046 in Combination with Axitinib for the Treatment of Advanced NSCLC at ESMO IO Congress 2024 2024-12-13 10:35
Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS 2024-12-13 08:00
Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs with Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS 2024-12-13 08:00
1 2 3 4 5 6 420